| |
|
|
|
|
|
|
|||
|
Blood, 3 September 2009, Vol. 114, No. 10, pp. 2159-2167. Prepublished online as a Blood First Edition Paper on July 9, 2009; DOI 10.1182/blood-2008-08-173963.
LYMPHOID NEOPLASIA Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1–positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP)1 Department of Hematology/Oncology L and A Seràgnoli S Orsola Malpighi Hospital, University of Bologna, Bologna; 2 Department of Genetics and Microbiology, University of Bari, Bari; 3 Department of Clinical and Biological Science, University of Turin at Orbassano, Turin; 4 Pediatric Oncology and Hematology L Seràgnoli, Bologna; 5 Department of Cellular Biotechnologies and Hematology, La Sapienza University, Rome; 6 Hematology and Bone Marrow Transplantation Unit, Spedali Civili Hospital, University of Brescia, Brescia; and 7 CEINGE Biotecnologie Avanzate and Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Naples, Italy
The BCR-ABL1 fusion gene defines the subgroup of acute lymphoblastic leukemia (ALL) with the worst clinical prognosis. To identify oncogenic lesions that combine with BCR-ABL1 to cause ALL, we used Affymetrix Genome-Wide Human SNP arrays (250K NspI and SNP 6.0), fluorescence in situ hybridization, and genomic polymerase chain reaction to study 106 cases of adult BCR-ABL1–positive ALL. The most frequent somatic copy number alteration was a focal deletion on 7p12 of IKZF1, which encodes the transcription factor Ikaros and was identified in 80 (75%) of 106 patients. Different patterns of deletions occurred, but the most frequent were those characterized by a loss of exons 4 through 7 (
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||